A persistent dyspnea induced by hydrochlorothiazide

Therapie. 2019 Sep;74(4):498-499. doi: 10.1016/j.therap.2019.03.009. Epub 2019 Apr 4.

Authors

Widd Kaabi¹, Imen Aouinti², Ons Charfi², Ahmed Zaiem², Ghozlane Lakhoua², Imen Hamza³, Riadh Daghfous², Sarrah Kastalli², Sihem El Aidli²

Affiliations

¹ National Centre of Pharmacovigilance, 1006 Tunis, Tunisia. Electronic address: widdkaabi@gmail.com.
² National Centre of Pharmacovigilance, 1006 Tunis, Tunisia; Tunis El Manar University, Medicine Faculty, Research Unit UR17ES12, La Rabta, 1007, Tunis, Tunisia.
³ National Centre of Pharmacovigilance, 1006 Tunis, Tunisia.

PMID: 31023617
DOI: 10.1016/j.therap.2019.03.009

No abstract available

Keywords: Dyspnea; Hydrochlorothiazide; Pharmacovigilance.

Publication types

Case Reports
Letter

MeSH terms

Antihypertensive Agents / adverse effects*
Dyspnea / chemically induced*
Dyspnea / diagnosis
Dyspnea / pathology
Female
Humans
Hydrochlorothiazide / adverse effects*
Hypertension / drug therapy*
Middle Aged

Substances

Antihypertensive Agents
Hydrochlorothiazide